EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Applications of transcranial focused ultrasound for primary brain tumors

Ahmad Ozair iD, Bilal Moiz iD, Pavlos Anastasiadis, Dheeraj Gandhi iD, Chetan Bettegowda iD, Paul S Mischel iD, Jinpyo Hong, Manmeet S Ahluwalia iD, Graeme F Woodworth iD

Neuro-Oncology Advances · 01.06.2026 · 8 (Supplement_4) · iv20-iv39

DOI: 10.1093/noajnl/vdaf156 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Neuro-Oncology Advances, online erschienen am 02.12.2025. Verfasst von Ahmad Ozair und 8 weiteren Autor:innen. Beteiligte Einrichtung: Brain Tumor Program, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, USA. Die Arbeit nennt 218 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCATS NIH HHS, Johns Hopkins and University of Maryland, Baltimore Institutes for Clinical and Translational Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Individuals diagnosed with primary brain tumors (PBTs) experience major morbidity and mortality, compounded by the risks associated with standard-of-care brain-directed therapeutic approaches. Recurrence remains inevitable in patients with high-grade gliomas (HGG), due to their brain-infiltrative growth hindering surgical removal, immunosuppressive tumor-microenvironment, dynamic disease evolution from their high cellular and molecular heterogeneity, and multi-faceted challenges to brain drug delivery, primarily stemming from the blood–brain barrier (BBB). This expert narrative review describes the current state of transcranial focused ultrasound (FUS), and its multi-modal applications for PBTs, including delivery of therapeutic agents and sono-liquid biopsy (via BBB opening), immunomodulation, radio-sensitization, and direct destruction of tumor cells/tissue via thermoablation, histotripsy, and sonodynamic therapy. BBB opening-based approaches have the most promising clinical evidence so far, warranting randomized comparative evalutions. Further translation will require standardized FUS treatment protocols, translational investigations nested into trials, coordinated global efforts, strategic trial design incorporating methodological advances, and implementation approaches enabling broader participation. Worldwide efforts to advance FUS will be aided by ongoing device evolution, support from professional societies, and the development of FUS research consortia (like ReFOCUSED). FUS applications open a potential combinatorial path forward with systemic therapies for “adaptive theragnostic” tumor management, thus targeting the root causes of therapeutic failure for HGG patients.

Schlagwörter

Stichwörter der Autor:innen

CNS cancerbrain malignancypulsed ultrasoundtherapeutic ultrasound

Autor:innen und Institutionen

  • Brain Tumor Program, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, USA.
  • Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Department of Neurology and Neurosurgery, McGill University, Montreal, Canada.
  • Fischell Department of Bioengineering, University of Maryland, College Park, Maryland, USA.
  • Department of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

ORCID-Profile: Ahmad Ozair, Bilal Moiz, Dheeraj Gandhi, Chetan Bettegowda, Paul S Mischel, Manmeet S Ahluwalia, Graeme F Woodworth

Förderung

  • NCATS NIH HHS
  • Johns Hopkins and University of Maryland
  • Baltimore Institutes for Clinical and Translational Research
  • National Center for Advancing Translational Sciences

Zitieren

APA

Ozair, A., Moiz, B., Anastasiadis, P., Gandhi, D., Bettegowda, C., Mischel, P. S., Hong, J., Ahluwalia, M. S., & Woodworth, G. F. (2026). Applications of transcranial focused ultrasound for primary brain tumors. Neuro-Oncology Advances, 8(Supplement_4), iv20-iv39. https://doi.org/10.1093/noajnl/vdaf156

Vancouver

Ozair A, Moiz B, Anastasiadis P, Gandhi D, Bettegowda C, Mischel PS, et al. Applications of transcranial focused ultrasound for primary brain tumors. Neuro-Oncology Advances. 2026;8(Supplement_4):iv20-iv39. doi:10.1093/noajnl/vdaf156

BibTeX
@article{Ozair2026,
  author = {Ozair, Ahmad and Moiz, Bilal and Anastasiadis, Pavlos and Gandhi, Dheeraj and Bettegowda, Chetan and Mischel, Paul S and Hong, Jinpyo and Ahluwalia, Manmeet S and Woodworth, Graeme F},
  title = {Applications of transcranial focused ultrasound for primary brain tumors},
  journal = {Neuro-Oncology Advances},
  year = {2026},
  volume = {8},
  number = {Supplement_4},
  pages = {iv20--iv39},
  doi = {10.1093/noajnl/vdaf156}
}
Kostenlos starten →